Frankincense Resin Extraction Plant
Gums & Resin Extraction Plants

Frankincense Resin Extraction Plant

Frankincense Resin Extraction Plant

Frankincense Resin Extraction Plant

Mechotech manufactures industrial frankincense resin extraction plants for Boswellia sacra (Omani/Dhofar frankincense), B. papyrifera (Ethiopian/Sudanese frankincense), and related Boswellia species, producing standardised frankincense extracts containing alpha-boswellic acid, incensole acetate, lupeolic acid, and a spectrum of pentacyclic triterpene boswellic acids valued in luxury fragrance, aromatherapy, pharmaceutical anti-inflammatory applications, and the global incense trade. Our ethanol-based solvent extraction plants process raw oleo-gum resin from artisanal collection to standardised extract at batch capacities from 100 kg to 3,000 kg raw resin per cycle.

Frankincense resin from Boswellia sacra (the species prized for Hojari and Royal Green frankincense from Dhofar, Oman) and B. papyrifera (African frankincense used widely in European and North American aromatherapy markets) has a distinct aromatic and chemical profile from Indian Boswellia serrata: higher essential oil content (8–12% vs 3–5% for B. serrata), different boswellic acid stereochemistry, the presence of incensole acetate (a key bioactive and aromatic compound with documented psychoactive properties via TRPV3 receptor activation), and lupeolic acid. Mechotech's frankincense extraction plants are designed to produce both the essential oil (by prior steam distillation) and the boswellic acid-rich resinoid extract (by subsequent ethanol extraction of the spent resin), maximising value from every kilogram of imported raw material.

Manufacturing Process

1

Resin Collection & Grading

Frankincense tears (dried resin exudate) are sourced from Oman, Ethiopia, Somalia, and Sudan through established import channels. Incoming resin is graded by tear size, colour (pale green Hojari to dark brown grades), and freedom from bark, dust, and sand. HPLC screening for total boswellic acids, alpha-boswellic acid, and incensole acetate content guides grade assignment. Higher grades (Hojari, Royal Green) command premium prices and are reserved for luxury fragrance and high-specification pharmaceutical extraction.

2

Comminution

Frankincense tears are broken and lightly crushed to 3–10 mm pieces in a jaw crusher. Over-grinding is avoided as it generates excessive fines that complicate filtration and increases essential oil loss by volatilisation during grinding. Where essential oil is to be extracted first by steam distillation (a combined process), the whole or coarsely broken tears are charged directly to the distillation still. For resinoid extraction only, the crushed resin proceeds directly to solvent dissolution.

3

Ethanol / Acetone Dissolution

Crushed resin is loaded into jacketed SS 316L extraction vessels and dissolved in 96% food-grade ethanol or technical acetone at 40–55°C with agitation at 5:1 to 8:1 solvent-to-resin ratio (v/w). Ethanol dissolves boswellic acids, incensole acetate, lupeolic acid, and the essential oil fraction. The water-soluble gum polysaccharides remain undissolved. Two extraction stages with fresh solvent maximise resinoid recovery. Closed-top vessels with nitrogen blanket prevent essential oil evaporation losses.

4

Filtration — Gum & Insoluble Removal

The resinoid-solvent solution is pressure-filtered through a leaf filter to remove the undissolved gum matrix, bark fragments, and particulate impurities. Polishing cartridge filtration (20 then 5 micron) produces a clear amber to dark brown solution. The gum cake is pressed to recover retained solvent. The filtrate is sampled for boswellic acid content and the yield-projected before proceeding to evaporation.

5

Vacuum Evaporation & Standardisation

Filtered solvent-resinoid solution is concentrated in a falling-film vacuum evaporator at 45–52°C and 60–90 mbar to recover solvent (>95%) and produce a concentrated frankincense resinoid paste. Essential oil fraction (if not pre-distilled) concentrates into the resinoid at this stage, contributing to the characteristic frankincense aroma. The concentrate is assayed by HPLC for boswellic acids and incensole acetate. Blending of batches achieves the target specification: minimum 30–50% total boswellic acids and 0.5–2% incensole acetate.

6

Spray Drying (Optional) & QC

For powdered frankincense extract (pharmaceutical and nutraceutical applications), the resinoid concentrate is blended with spray-drying excipient (maltodextrin or silicon dioxide) and spray-dried to produce a free-flowing powder at moisture below 5%. For luxury fragrance and incense applications, the semi-solid resinoid is the preferred form. QC testing covers HPLC assay for boswellic acids and incensole acetate, specific gravity, refractive index, residual solvents by headspace GC, heavy metals, aflatoxins, and microbial counts.

Applications

  • Luxury fragrance — frankincense absolute and resinoid are prized base notes in Chypre, Oriental, and spiritual fragrance compositions, used in premium perfumes at 0.5–5% concentration for longevity and depth
  • Aromatherapy — frankincense resinoid and essential oil used in diffusers, massage oils, and bath preparations for their documented anti-anxiety, mood-lifting, and spiritual-use benefits
  • Pharmaceutical anti-inflammatory — standardised frankincense extract (boswellic acids) used in joint health supplements and herbal medicines for osteoarthritis and inflammatory conditions
  • Incense and spiritual products — frankincense resin burned directly as incense or incorporated into premium incense sticks, resins, dhoop, and church/temple incense across religious traditions
  • Cosmetics and skin care — frankincense resinoid and boswellic acid extract used in anti-aging serums, face oils, and luxury skin care products for their documented anti-inflammatory and skin-tightening activities
  • Traditional medicine (Ayurveda / Unani / East African) — frankincense resin used in traditional healing systems for respiratory conditions, wound healing, and anti-inflammatory applications
  • Nutraceuticals and food supplements — frankincense extract standardised for boswellic acids marketed for cognitive health, anti-inflammatory, and joint mobility support

Key Features

  • Dual-Mode Essential Oil + Resinoid Extraction

    Mechotech's frankincense plant includes an optional steam distillation stage before solvent extraction, allowing steam distillation of the volatile essential oil (terpene fraction including alpha-pinene, limonene, and sabinene) from the raw resin before ethanol extraction of the remaining resinoid boswellic acid fraction. This dual extraction maximises value recovery — the essential oil commands premium aromatherapy pricing, and the residual resin is still rich in boswellic acids for pharmaceutical extraction.

  • Incensole Acetate Preservation Protocol

    Incensole acetate, the bioactive compound responsible for frankincense's documented psychoactive and anxiolytic effects via TRPV3 receptor activation, is sensitive to hydrolysis at elevated temperature and pH. Mechotech's extraction conditions (low temperature, pH-neutral ethanol, sub-52°C evaporation) are specifically designed to preserve incensole acetate in the finished resinoid, which is a key quality marker for fragrance and neuroscientific research applications.

  • Species-Specific Process Configuration

    Boswellia sacra (Omani frankincense) and B. papyrifera (African frankincense) have different resin compositions — sacra has higher essential oil and incensole acetate content; papyrifera has higher gum content and different boswellic acid ratios. Mechotech configures extraction parameters (solvent type, temperature, filtration) and provides species-specific QC methods for each species, ensuring the extract from each source meets its target specification.

  • GMP SS 316L Construction

    All product-contact equipment is fabricated in SS 316L with electro-polished internal surfaces, food-grade PTFE or silicone gaskets, and CIP cleaning systems. The plant meets WHO-GMP and AYUSH GMP standards for herbal pharmaceutical ingredient manufacture, supporting production of frankincense extract for licensed Ayurvedic medicines and regulated health food supplements.

  • Closed-Loop Ethanol Recovery (>95%)

    The falling-film evaporation and condensation system recovers ethanol at greater than 95% efficiency per batch. Recovered ethanol is tested for concentration (target 95–96% v/v) and purity before return to the extraction stage. This solvent recovery system makes frankincense extraction economically viable despite the high cost of food-grade ethanol and the relatively small batch sizes typical of premium resin processing.

Frequently Asked Questions

What is the difference between frankincense from Boswellia sacra and Boswellia serrata for extraction purposes?
Boswellia serrata (Indian frankincense / shallaki) is the pharmaceutical species used for anti-inflammatory boswellic acid standardised extract, primarily for osteoarthritis medicines. It has lower essential oil (3–5%), higher boswellic acid content, and lacks significant incensole acetate. Boswellia sacra (Omani / Dhofar frankincense) has higher essential oil (8–12%), strong aromatic profile including incensole acetate, and is the species valued in luxury fragrance, aromatherapy, and spiritual contexts. B. papyrifera (African species) is widely used in aromatherapy markets at lower cost. The extraction plant processes all species, but the process conditions and target QC markers differ significantly.
What is incensole acetate and what are its documented effects?
Incensole acetate is a bicyclic diterpene compound (C22H34O4) found primarily in Boswellia sacra and B. papyrifera resin. It is not present in significant amounts in B. serrata. A 2008 study published in FASEB Journal (Moussaieff et al.) demonstrated that incensole acetate activates TRPV3 ion channels in the brain, producing anxiolytic and antidepressant effects in mice. This is believed to be the mechanism behind frankincense's traditional use in religious contexts to produce a spiritual or meditative mental state. The compound is now an active area of pharmacological research and is a key differentiating quality marker for Boswellia sacra extracts targeting aromatherapy and mood-support applications.
Can I also produce frankincense essential oil from the same plant?
Yes, and Mechotech recommends the combined essential oil + resinoid process for maximum value recovery. In the first stage, raw frankincense tears are steam-distilled in a dedicated still to recover the essential oil fraction (approximately 3–12% of resin weight depending on species, grade, and freshness). The steam-distilled residue retains most of the boswellic acids and is then processed by ethanol extraction to produce the resinoid. This two-product process generates both a premium essential oil (for aromatherapy and fragrance) and a boswellic acid-standardised resinoid (for pharmaceutical and nutraceutical use) from each kilogram of raw resin, significantly improving overall revenue per kilogram of imported material.
What import documentation is required for frankincense resin in India, and how does Mechotech support compliance?
Frankincense resin (Boswellia sacra, B. papyrifera) imported into India requires: a standard commercial import licence and IEC (Importer Exporter Code); phytosanitary certificate from the country of export; CITES permit is not currently required for most Boswellia species (B. sacra and B. papyrifera are not CITES-listed as of 2025, though this may change); Drug Import Licence if the resin is to be processed as a pharmaceutical herbal ingredient. Mechotech provides documentation checklists and connects clients with experienced customs clearing agents familiar with herbal raw material imports from Oman, Ethiopia, and Somalia.

Ready to discuss your project?

Get a free quote and technical consultation from our engineering team.

Get A Free Quote
Review Us